Should your company pursue reimbursement during clinical trials? In this video, we break down the strategic considerations every medtech company needs to evaluate before diving into trial reimbursement.
We’ll cover the key questions that can make or break your reimbursement strategy: the real upsides and potential pitfalls of seeking payment during trials, how to leverage Category III CPT codes to establish early value propositions, and critical pricing considerations that set you up for post-approval success.
Whether you’re a startup planning your first pivotal trial or an established company expanding into new indications, this strategic framework will help you make informed decisions about when trial reimbursement makes sense for your business.
Key topics discussed:
- Strategic framework for evaluating trial reimbursement opportunities
- Pros and cons of pursuing payment during clinical development
- Using Category III CPT codes as a value establishment tool
- Pricing strategy considerations for investigational products
- Risk mitigation and timeline implications
Perfect for executives, business development teams, and anyone involved in commercialization planning for medical devices and diagnostics.
#ClinicalTrials #MedicalDevices #Reimbursement #HealthcareStrategy #MedTech #CPTCodes #PricingStrategy